Registered entities
APTIMMUNE BIOLOGICS, INC.
Reg. No. 272467088United States
Innovation
2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 44 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Investor mix
10 investors on record; lead investors include Arsenal Capital Partners, Fox Ventures, St. Louis Arch Angels, Missouri Technology.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Private equity | 1 | 10% |
| Angel & family office | 1 | 10% |
| Other / undisclosed | 1 | 10% |
